Cargando…

A robust CD8(+) T cell-related classifier for predicting the prognosis and efficacy of immunotherapy in stage III lung adenocarcinoma

Patients with stage III lung adenocarcinoma (LUAD) have significant survival heterogeneity, meanwhile, CD8(+) T cell has a remarkable function in immunotherapy. Therefore, developing novel biomarkers based on CD8(+) T cell can help evaluate the prognosis and guide the strategy of immunotherapy for p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feng, Jinteng, Xu, Longwen, Zhang, Shirong, Geng, Luying, Zhang, Tian, Yu, Yang, Yuan, Rui, He, Yusheng, Nan, Zhuhui, Lin, Min, Guo, Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9471021/ https://www.ncbi.nlm.nih.gov/pubmed/36119068 http://dx.doi.org/10.3389/fimmu.2022.993187

Ejemplares similares

ncRNAs-mediated overexpression of STIL predict unfavorable prognosis and correlated with the efficacy of immunotherapy of hepatocellular carcinoma
por: Xu, Longwen, et al.
Publicado: (2023)

ASF1B is a Promising Prognostic Biomarker and Correlates With Immunotherapy Efficacy in Hepatocellular Carcinoma
por: Zhang, Shirong, et al.
Publicado: (2022)

CD8(+) T Cell-Associated Gene Signature Correlates With Prognosis Risk and Immunotherapy Response in Patients With Lung Adenocarcinoma
por: Zhang, Minghui, et al.
Publicado: (2022)

PTPRO-related CD8(+) T-cell signatures predict prognosis and immunotherapy response in patients with breast cancer
por: Dong, Hongmei, et al.
Publicado: (2022)

Development and validation of a robust necroptosis related classifier for colon adenocarcinoma
por: Yang, Jie, et al.
Publicado: (2022)

IRGS: an immune-related gene classifier for lung adenocarcinoma prognosis
por: Shi, Xiaoshun, et al.
Publicado: (2020)

Prediction of prognosis and immunotherapy response in lung adenocarcinoma based on CD79A, DKK1 and VEGFC
por: Zhang, Qilong, et al.
Publicado: (2023)

XGBoost Classifier Based on Computed Tomography Radiomics for Prediction of Tumor-Infiltrating CD8(+) T-Cells in Patients With Pancreatic Ductal Adenocarcinoma
por: Li, Jing, et al.
Publicado: (2021)

The Comprehensive Analysis Identified an Autophagy Signature for the Prognosis and the Immunotherapy Efficiency Prediction in Lung Adenocarcinoma
por: Li, Xizhe, et al.
Publicado: (2022)

A novel immune checkpoints-based signature to predict prognosis and response to immunotherapy in lung adenocarcinoma
por: Sun, Nan, et al.
Publicado: (2022)

An endoplasmic reticulum stress-related signature could robustly predict prognosis and closely associate with response to immunotherapy in pancreatic ductal adenocarcinoma
por: Liu, Shuguang, et al.
Publicado: (2023)

A novel methionine metabolism-related signature predicts prognosis and immunotherapy response in lung adenocarcinoma
por: Chang, Qing-Hua, et al.
Publicado: (2023)

Identification of CD318, TSPAN8 and CD66c as target candidates for CAR T cell based immunotherapy of pancreatic adenocarcinoma
por: Schäfer, Daniel, et al.
Publicado: (2021)

Integrative analysis of TP53 mutations in lung adenocarcinoma for immunotherapies and prognosis
por: Li, He, et al.
Publicado: (2023)

Comprehensive analysis of the prognosis, tumor microenvironment, and immunotherapy response of SDHs in colon adenocarcinoma
por: Nan, Han, et al.
Publicado: (2023)

Identification of a costimulatory molecule-based signature for predicting prognosis risk and immunotherapy response in patients with lung adenocarcinoma
por: Zhang, Chaoqi, et al.
Publicado: (2020)

Combining classifiers for robust PICO element detection
por: Boudin, Florian, et al.
Publicado: (2010)

Constraining classifiers in molecular analysis: invariance and robustness
por: Lausser, Ludwig, et al.
Publicado: (2020)

Classification of colon adenocarcinoma based on immunological characterizations: Implications for prognosis and immunotherapy
por: Xu, Midie, et al.
Publicado: (2022)

Consensus Molecular Subtypes Efficiently Classify Gastric Adenocarcinomas and Predict the Response to Anti-PD-1 Immunotherapy
por: Wu, Xiangyan, et al.
Publicado: (2022)

The Prognostic Model Established by the Differential Expression Genes Based on CD8(+) T Cells to Evaluate the Prognosis and the Response to Immunotherapy in Osteosarcoma
por: Chen, Yu, et al.
Publicado: (2023)

Assessment of POLE and POLD1 mutations as prognosis and immunotherapy biomarkers for stomach adenocarcinoma
por: Zhu, Mingyu, et al.
Publicado: (2022)

A robust classifier of high predictive value to identify good prognosis patients in ER-negative breast cancer
por: Teschendorff, Andrew E, et al.
Publicado: (2008)

Learning from small medical data—robust semi-supervised cancer prognosis classifier with Bayesian variational autoencoder
por: Hsu, Te-Cheng, et al.
Publicado: (2023)

Construction of immune-related LncRNAs classifier to predict prognosis and immunotherapy response in thymic epithelial tumors
por: Su, Yongchao, et al.
Publicado: (2022)

Identification of a novel necroptosis-related classifier to predict prognosis and guide immunotherapy in breast invasive carcinoma
por: Zhou, Qin, et al.
Publicado: (2022)

High expression of CD8 predicts favorable prognosis in patients with lung adenocarcinoma: A cohort study
por: Ye, Sheng-Lan, et al.
Publicado: (2017)

Advances in immunotherapy modalities for atherosclerosis
por: Meng, Qingwen, et al.
Publicado: (2023)

Comprehensive molecular analyses of a TNF family-based signature with regard to prognosis, immune features, and biomarkers for immunotherapy in lung adenocarcinoma
por: Zhang, Chaoqi, et al.
Publicado: (2020)

Robust Framework to Combine Diverse Classifiers Assigning Distributed Confidence to Individual Classifiers at Class Level
por: Khalid, Shehzad, et al.
Publicado: (2014)

Framework for Testing Robustness of Machine Learning-Based Classifiers
por: Chuah, Joshua, et al.
Publicado: (2022)

CD8(+) Tumour-Infiltrating Lymphocytes and Tumour Microenvironment Immune Types as Biomarkers for Immunotherapy in Sinonasal Intestinal-Type Adenocarcinoma
por: García-Marín, Rocío, et al.
Publicado: (2020)

Association of collagen deep learning classifier with prognosis and chemotherapy benefits in stage II‐III colon cancer
por: Jiang, Wei, et al.
Publicado: (2023)

The difference and relationship of CD4+ and CD8+ tumour infiltrating lymphocytes in lung adenocarcinoma
por: Zhang, Chaoting, et al.
Publicado: (2019)

Elevated pretreatment plasma D-dimer levels and platelet counts predict poor prognosis in pancreatic adenocarcinoma
por: Liu, Peng, et al.
Publicado: (2015)

APOBEC mutational signature predicts prognosis and immunotherapy response in nonsmoking patients with lung adenocarcinoma
por: Ma, Jianli, et al.
Publicado: (2023)

Identification of Immune Subtypes of Esophageal Adenocarcinoma to Predict Prognosis and Immunotherapy Response
por: Ling, Chen, et al.
Publicado: (2022)

Robust Prediction of Prognosis and Immunotherapy Response for Bladder Cancer through Machine Learning Algorithm
por: Hu, Shanshan, et al.
Publicado: (2022)

Identification and Validation of Immune Molecular Subtypes in Pancreatic Ductal Adenocarcinoma: Implications for Prognosis and Immunotherapy
por: Li, Ruiyu, et al.
Publicado: (2021)

Improving the robustness and stability of a machine learning model for breast cancer prognosis through the use of multi-modal classifiers
por: Arya, Nikhilanand, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_79eghr784clsq2ob06tl5iot36